Bill Bonello Maintained (AKYA) at Strong Buy with Decreased Target to $7 on, Aug 6th, 2024
Bill Bonello of Craig-Hallum, Maintained "Akoya Biosciences, Inc." (AKYA) at Strong Buy with Decreased Target from $7.5 to $7 on, Aug 6th, 2024.
Bill has made no other calls on AKYA in the last 4 months.
There is 1 other peer that has a rating on AKYA. Out of the 1 peers that are also analyzing AKYA, 0 agree with Bill's Rating of Hold.
This is the rating of the analyst that currently disagrees with Bill
- Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, May 14th, 2024
Contributing Sources